Effect of BrainPhyt High Dose on Cognitive Function in Healthy Older Individuals — PHAEO-FOUR

Age-associated Memory Impairment Clinical Trial

Official title:
A Randomised, Double-blind, Placebo-controlled, Parallel Study of the Effect of BrainPhyt High Dose on Cognitive Function in Healthy Older Individuals

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate if BrainPhyt, a microalgae based ingredient may affect cognitive function parameters in older healthy individuals with evidence of age-related cognitive decline. In a double blind, randomized manner, 40 free living males and females between 55 to 75 years with age-associated memory decline will ingest Brainphyt supplement or Placebo for 12 weeks. Cognitive function battery will be realized after 4 and 12 weeks of supplementation.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Age-associated Memory Impairment

Clinical Trial Details

NCT number	NCT05759910
Study type	Interventional
Source	Microphyt
Contact
Status	Completed
Phase	N/A
Start date	May 1, 2022
Completion date	November 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05910047` - Supplemental Hydrogen Plus PQQ for Mitochondrial Biomarkers and Brain Function in Elderly With Mild Cognitive Impairment	N/A
Completed	`NCT01429103` - Hormones and Cognition in the Menopausal Transition	N/A
Completed	`NCT00355550` - Tricaprilin In Age-Associated Memory Impairment	Phase 2
Terminated	`NCT05462782` - TMS for Investigating Memory Facilitation	N/A
Recruiting	`NCT05934344` - Effectiveness of an Intervention Using Observation/Action Therapy Among Patients With Mild Cognitive Impairment	N/A